Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride

Introduction A multinational post-authorization safety study assessed cardiovascular safety in initiators of prucalopride for chronic constipation compared with a matched cohort of polyethylene glycol 3350 initiators. The primary safety outcome was major adverse cardiovascular events (MACE), a compo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug safety Jg. 44; H. 5; S. 541 - 551
Hauptverfasser:	Ruigómez, Ana, Plana, Estel, Gilsenan, Alicia, Fortuny, Joan, Cainzos-Achirica, Miguel, Flynn, Robert W. V., MacDonald, Thomas M., Garcia-Rodriguez, Luis, Ziemiecki, Ryan, Andrews, Elizabeth B.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Cham Springer International Publishing 01.05.2021 Springer Nature B.V
Schlagworte:	Adjudication Algorithms Automation Benzofurans - adverse effects Cerebral infarction Clinical medicine Constipation Data sources Databases, Factual Drug Safety and Pharmacovigilance Electronic Health Records Gold Heart attacks Hospitalization Hospitals Humans Information services Information Storage and Retrieval Initiators Medical records Medicine Medicine & Public Health Myocardial infarction Myocardial Infarction - chemically induced Myocardial Infarction - epidemiology Original Original Research Article Patients Pharmacology/Toxicology Polyethylene glycol Practice research Questionnaires Safety Stroke United Kingdom - epidemiology United Kingdom United Kingdom > UK Scotland
ISSN:	0114-5916, 1179-1942, 1179-1942
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Introduction A multinational post-authorization safety study assessed cardiovascular safety in initiators of prucalopride for chronic constipation compared with a matched cohort of polyethylene glycol 3350 initiators. The primary safety outcome was major adverse cardiovascular events (MACE), a composite of hospitalization for acute myocardial infarction, stroke, or in-hospital cardiovascular death. We report the validation process for MACE endpoints in United Kingdom (UK) data sources: Clinical Practice Research Datalink (CPRD GOLD), The Health Improvement Network (THIN), and the Information Services Division (ISD) Scotland. Methods Modified electronic algorithms from prior research identified potential MACE cases. Validation followed a common protocol, adapted for each database, with all information anonymized: (1) direct confirmation via linkage to hospital records (CPRD GOLD); (2) requests for additional clinical information through questionnaires (CPRD GOLD), free-text (THIN), or abstraction of hospital records (ISD); (3) manual review of electronic records of potential events retrieved by the algorithm (CPRD GOLD/THIN); and (4) event adjudication by three clinicians, blinded to exposure, for all remaining events. Results Electronic algorithms identified 260 potential MACE cases: 38 confirmed via linkage to hospital records (CPRD GOLD), 56 ruled out as non-cardiovascular death cases (THIN), and three unavailable for review (ISD), leaving 163 potential cases. After manual review with additional information (steps 2 and 3), 45 were considered noncases (CPRD GOLD/THIN). Upon final adjudication (step 4), remaining potential events were adjudicated as definite ( n = 62), probable ( n = 10), possible ( n = 13), or noncases ( n = 33). Conclusions Given the limitations of relying solely on computer algorithms to identify cardiovascular outcomes, validation with clinical review is essential to guide interpretation.
AbstractList	Introduction A multinational post-authorization safety study assessed cardiovascular safety in initiators of prucalopride for chronic constipation compared with a matched cohort of polyethylene glycol 3350 initiators. The primary safety outcome was major adverse cardiovascular events (MACE), a composite of hospitalization for acute myocardial infarction, stroke, or in-hospital cardiovascular death. We report the validation process for MACE endpoints in United Kingdom (UK) data sources: Clinical Practice Research Datalink (CPRD GOLD), The Health Improvement Network (THIN), and the Information Services Division (ISD) Scotland. Methods Modified electronic algorithms from prior research identified potential MACE cases. Validation followed a common protocol, adapted for each database, with all information anonymized: (1) direct confirmation via linkage to hospital records (CPRD GOLD); (2) requests for additional clinical information through questionnaires (CPRD GOLD), free-text (THIN), or abstraction of hospital records (ISD); (3) manual review of electronic records of potential events retrieved by the algorithm (CPRD GOLD/THIN); and (4) event adjudication by three clinicians, blinded to exposure, for all remaining events. Results Electronic algorithms identified 260 potential MACE cases: 38 confirmed via linkage to hospital records (CPRD GOLD), 56 ruled out as non-cardiovascular death cases (THIN), and three unavailable for review (ISD), leaving 163 potential cases. After manual review with additional information (steps 2 and 3), 45 were considered noncases (CPRD GOLD/THIN). Upon final adjudication (step 4), remaining potential events were adjudicated as definite ( n = 62), probable ( n = 10), possible ( n = 13), or noncases ( n = 33). Conclusions Given the limitations of relying solely on computer algorithms to identify cardiovascular outcomes, validation with clinical review is essential to guide interpretation. Introduction A multinational post-authorization safety study assessed cardiovascular safety in initiators of prucalopride for chronic constipation compared with a matched cohort of polyethylene glycol 3350 initiators. The primary safety outcome was major adverse cardiovascular events (MACE), a composite of hospitalization for acute myocardial infarction, stroke, or in-hospital cardiovascular death. We report the validation process for MACE endpoints in United Kingdom (UK) data sources: Clinical Practice Research Datalink (CPRD GOLD), The Health Improvement Network (THIN), and the Information Services Division (ISD) Scotland. Methods Modified electronic algorithms from prior research identified potential MACE cases. Validation followed a common protocol, adapted for each database, with all information anonymized: (1) direct confirmation via linkage to hospital records (CPRD GOLD); (2) requests for additional clinical information through questionnaires (CPRD GOLD), free-text (THIN), or abstraction of hospital records (ISD); (3) manual review of electronic records of potential events retrieved by the algorithm (CPRD GOLD/THIN); and (4) event adjudication by three clinicians, blinded to exposure, for all remaining events. Results Electronic algorithms identified 260 potential MACE cases: 38 confirmed via linkage to hospital records (CPRD GOLD), 56 ruled out as non-cardiovascular death cases (THIN), and three unavailable for review (ISD), leaving 163 potential cases. After manual review with additional information (steps 2 and 3), 45 were considered noncases (CPRD GOLD/ THIN). Upon final adjudication (step 4), remaining potential events were adjudicated as definite (n = 62), probable (n = 10), possible (n = 13), or noncases (n = 33). Conclusions Given the limitations of relying solely on computer algorithms to identify cardiovascular outcomes, validation with clinical review is essential to guide interpretation. A multinational post-authorization safety study assessed cardiovascular safety in initiators of prucalopride for chronic constipation compared with a matched cohort of polyethylene glycol 3350 initiators. The primary safety outcome was major adverse cardiovascular events (MACE), a composite of hospitalization for acute myocardial infarction, stroke, or in-hospital cardiovascular death. We report the validation process for MACE endpoints in United Kingdom (UK) data sources: Clinical Practice Research Datalink (CPRD GOLD), The Health Improvement Network (THIN), and the Information Services Division (ISD) Scotland. Modified electronic algorithms from prior research identified potential MACE cases. Validation followed a common protocol, adapted for each database, with all information anonymized: (1) direct confirmation via linkage to hospital records (CPRD GOLD); (2) requests for additional clinical information through questionnaires (CPRD GOLD), free-text (THIN), or abstraction of hospital records (ISD); (3) manual review of electronic records of potential events retrieved by the algorithm (CPRD GOLD/THIN); and (4) event adjudication by three clinicians, blinded to exposure, for all remaining events. Electronic algorithms identified 260 potential MACE cases: 38 confirmed via linkage to hospital records (CPRD GOLD), 56 ruled out as non-cardiovascular death cases (THIN), and three unavailable for review (ISD), leaving 163 potential cases. After manual review with additional information (steps 2 and 3), 45 were considered noncases (CPRD GOLD/THIN). Upon final adjudication (step 4), remaining potential events were adjudicated as definite (n = 62), probable (n = 10), possible (n = 13), or noncases (n = 33). Given the limitations of relying solely on computer algorithms to identify cardiovascular outcomes, validation with clinical review is essential to guide interpretation. A multinational post-authorization safety study assessed cardiovascular safety in initiators of prucalopride for chronic constipation compared with a matched cohort of polyethylene glycol 3350 initiators. The primary safety outcome was major adverse cardiovascular events (MACE), a composite of hospitalization for acute myocardial infarction, stroke, or in-hospital cardiovascular death. We report the validation process for MACE endpoints in United Kingdom (UK) data sources: Clinical Practice Research Datalink (CPRD GOLD), The Health Improvement Network (THIN), and the Information Services Division (ISD) Scotland.INTRODUCTIONA multinational post-authorization safety study assessed cardiovascular safety in initiators of prucalopride for chronic constipation compared with a matched cohort of polyethylene glycol 3350 initiators. The primary safety outcome was major adverse cardiovascular events (MACE), a composite of hospitalization for acute myocardial infarction, stroke, or in-hospital cardiovascular death. We report the validation process for MACE endpoints in United Kingdom (UK) data sources: Clinical Practice Research Datalink (CPRD GOLD), The Health Improvement Network (THIN), and the Information Services Division (ISD) Scotland.Modified electronic algorithms from prior research identified potential MACE cases. Validation followed a common protocol, adapted for each database, with all information anonymized: (1) direct confirmation via linkage to hospital records (CPRD GOLD); (2) requests for additional clinical information through questionnaires (CPRD GOLD), free-text (THIN), or abstraction of hospital records (ISD); (3) manual review of electronic records of potential events retrieved by the algorithm (CPRD GOLD/THIN); and (4) event adjudication by three clinicians, blinded to exposure, for all remaining events.METHODSModified electronic algorithms from prior research identified potential MACE cases. Validation followed a common protocol, adapted for each database, with all information anonymized: (1) direct confirmation via linkage to hospital records (CPRD GOLD); (2) requests for additional clinical information through questionnaires (CPRD GOLD), free-text (THIN), or abstraction of hospital records (ISD); (3) manual review of electronic records of potential events retrieved by the algorithm (CPRD GOLD/THIN); and (4) event adjudication by three clinicians, blinded to exposure, for all remaining events.Electronic algorithms identified 260 potential MACE cases: 38 confirmed via linkage to hospital records (CPRD GOLD), 56 ruled out as non-cardiovascular death cases (THIN), and three unavailable for review (ISD), leaving 163 potential cases. After manual review with additional information (steps 2 and 3), 45 were considered noncases (CPRD GOLD/THIN). Upon final adjudication (step 4), remaining potential events were adjudicated as definite (n = 62), probable (n = 10), possible (n = 13), or noncases (n = 33).RESULTSElectronic algorithms identified 260 potential MACE cases: 38 confirmed via linkage to hospital records (CPRD GOLD), 56 ruled out as non-cardiovascular death cases (THIN), and three unavailable for review (ISD), leaving 163 potential cases. After manual review with additional information (steps 2 and 3), 45 were considered noncases (CPRD GOLD/THIN). Upon final adjudication (step 4), remaining potential events were adjudicated as definite (n = 62), probable (n = 10), possible (n = 13), or noncases (n = 33).Given the limitations of relying solely on computer algorithms to identify cardiovascular outcomes, validation with clinical review is essential to guide interpretation.CONCLUSIONSGiven the limitations of relying solely on computer algorithms to identify cardiovascular outcomes, validation with clinical review is essential to guide interpretation.
Author	Cainzos-Achirica, Miguel Andrews, Elizabeth B. Fortuny, Joan Ruigómez, Ana MacDonald, Thomas M. Flynn, Robert W. V. Plana, Estel Garcia-Rodriguez, Luis Gilsenan, Alicia Ziemiecki, Ryan
Author_xml	– sequence: 1 givenname: Ana surname: Ruigómez fullname: Ruigómez, Ana organization: Centro Español de Investigación Farmacoepidemiológica (CEIFE) – sequence: 2 givenname: Estel surname: Plana fullname: Plana, Estel organization: RTI Health Solutions – sequence: 3 givenname: Alicia surname: Gilsenan fullname: Gilsenan, Alicia email: agilsenan@rti.org organization: RTI Health Solutions – sequence: 4 givenname: Joan surname: Fortuny fullname: Fortuny, Joan organization: RTI Health Solutions – sequence: 5 givenname: Miguel surname: Cainzos-Achirica fullname: Cainzos-Achirica, Miguel organization: Division of Cardiovascular Prevention and Wellness, Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Center for Outcomes Research, Houston Methodist – sequence: 6 givenname: Robert W. V. surname: Flynn fullname: Flynn, Robert W. V. organization: University of Dundee – sequence: 7 givenname: Thomas M. surname: MacDonald fullname: MacDonald, Thomas M. organization: University of Dundee – sequence: 8 givenname: Luis surname: Garcia-Rodriguez fullname: Garcia-Rodriguez, Luis organization: Centro Español de Investigación Farmacoepidemiológica (CEIFE) – sequence: 9 givenname: Ryan surname: Ziemiecki fullname: Ziemiecki, Ryan organization: RTI Health Solutions – sequence: 10 givenname: Elizabeth B. surname: Andrews fullname: Andrews, Elizabeth B. organization: RTI Health Solutions
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/33606202$$D View this record in MEDLINE/PubMed
BookMark	eNp9UstuFDEQtFAQ2QR-gAOyxIXLgO3xPHxBQkuAFYmItISr1bE9u17N2okfkZZv4iPxZhIeOeRkWV1VXd1dR-jAeWcQeknJW0pI9y5ywlpeEUYrQgnnFX-CZpR2oqKCswM0I5TyqhG0PURHMW4IIT1r-2fosK5b0jLCZujXQhuX7GAVJOsdBqfxDxitnr5-wGew8QHPIWjrbyCqPELAJzeFFbF1OK0NvnA2GY2_WrfSfos_QgK89DkoE_HCqTHrUi1YwGd5TLYq4nAJ0eBzH1MFOa19sD-njksYTNrhZcp6t29_HrKC0V8Fq81z9HSAMZoXd-8xuvh08n3-pTr99nkx_3BaKd7xVPW87loOHed9o4ymehADtGJomqbWqtYEmIaBMSYYrwnTbOBc9UTURjQ960x9jN5Pulf5cmu0KrMGGGXxsIWwkx6s_L_i7Fqu_I3sSVPTRhSBN3cCwV9nE5Pc2qjMOIIzPkfJuCgn6ihjBfr6AXRTNufKeJI1tGNFTfCCevWvoz9W7g9ZAP0EUMHHGMwglU23Gy0G7SgpkfvMyCkzsmRG3mZG7rXZA-q9-qOkeiLFAnYrE_7afoT1G2QK1l8
CitedBy_id	crossref_primary_10_1016_j_jclinane_2025_111778
Cites_doi	10.1161/STR.0b013e318296aeca 10.1002/pds.5150 10.1002/pds.1888 10.1002/pds.1919 10.1002/pds.3277 10.1002/pds.1619 10.1161/CIRCOUTCOMES.108.805689 10.1007/s40264-019-00835-0 10.1093/ije/30.suppl_1.S30 10.1161/CIR.0b013e31826e1058 10.1186/1471-2458-11-450 10.1055/s-0030-1249688 10.1007/s00772-020-679-4 10.1097/01.gme.0000233494.28335.71 10.1002/pds.1518 10.1161/01.STR.0000226642.55207.94 10.1002/pds.4396 10.1007/s40264-019-00836-z
ContentType	Journal Article
Copyright	The Author(s) 2021 Copyright Springer Nature B.V. May 2021
Copyright_xml	– notice: The Author(s) 2021 – notice: Copyright Springer Nature B.V. May 2021
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 4T- 7RV 7T2 7TK 7U7 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR C1K CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM
DOI	10.1007/s40264-021-01044-4
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Docstoc Nursing & allied health premium. Health and Safety Science Abstracts (Full archive) Neurosciences Abstracts Toxicology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central - New (Subscription) Environmental Sciences and Pollution Management ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection Health & Safety Science Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Toxicology Abstracts ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Docstoc ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	ProQuest One Academic Middle East (New) MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Public Health Pharmacy, Therapeutics, & Pharmacology
EISSN	1179-1942
EndPage	551
ExternalDocumentID	PMC8053159 33606202 10_1007_s40264_021_01044_4
Genre	Research Support, Non-U.S. Gov't Journal Article
GeographicLocations	United Kingdom United Kingdom--UK Scotland
GeographicLocations_xml	– name: United Kingdom – name: United Kingdom--UK – name: Scotland
GrantInformation_xml	– fundername: Shire Pharmaceuticals GmbH, now part of the Takeda group of companies – fundername: ;
GroupedDBID	--- -EM 04C 0R~ 199 29G 2JY 36B 3V. 4.4 406 53G 5GY 5RE 6I2 6PF 7RV 7X7 88E 8FI 8FJ 8R4 8R5 95. AAAUJ AACDK AADNT AAIAL AAIKX AAJKR AAKAS AANZL AARHV AASML AATNV AAWTL AAYOK AAYQN AAYTO AAYZH ABAKF ABDZT ABFTV ABIPD ABJNI ABJOX ABKCH ABKMS ABKTR ABLLE ABMNI ABOCM ABPLI ABTKH ABTMW ABUWG ABWHX ABXPI ACAOD ACCOQ ACCUX ACDTI ACGFO ACGFS ACMJI ACMLO ACOKC ACPIV ACPRK ACREN ACZOJ ADBBV ADFRT ADFZG ADJJI ADQRH ADRFC ADURQ ADYOE ADZCM ADZKW AEBTG AEFQL AEJHL AEJRE AEMSY AENEX AEOHA AEPYU AESKC AEVLU AEXYK AEYRQ AFBBN AFKRA AFRAH AFWTZ AFZKB AGAYW AGDGC AGQEE AGQMX AGRTI AHIZS AHMBA AHSBF AIAKS AIGIU AILAN AIZAD AJRNO ALMA_UNASSIGNED_HOLDINGS AMKLP AMXSW AMYLF ASPBG AVWKF AWSVR AXYYD AZFZN A~4 BENPR BGNMA BKEYQ BPHCQ BVXVI BYPQX C6C CAG CCPQU COF CS3 DCUDU DNIVK DPUIP DU5 EBLON EBS EJD EMOBN ESX EX3 F5P FERAY FIGPU FLLZZ FNLPD FSGXE FYUFA HMCUK IAO IHR IMOTQ INH INR ITC IWAJR J-C J5H JZLTJ L7B LGEZI LLZTM LOTEE M1P M4Y NADUK NAPCQ NQJWS NU0 NXXTH O9- OAC OPC OVD P2P PQQKQ PROAC PSQYO Q2X ROL RSV RZALA SISQX SJYHP SNPRN SNX SOHCF SOJ SPKJE SRMVM SSLCW TEORI TSG U9L UAX UG4 UKHRP UTJUX VDBLX VFIZW W48 WAF WOW YFH YQY Z0Y ZGI ZXP ~JE AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFFHD AFHIU AFOHR AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY CGR CUY CVF ECM EIF NPM 4T- 7T2 7TK 7U7 7XB 8FK C1K K9. PKEHL PQEST PQUKI PRINS 7X8 5PM
ID	FETCH-LOGICAL-c474t-843764a74485ced1df9fa69f5553dc3d0a2daf222924302d2f44c8093e95827e3
IEDL.DBID	7RV
ISICitedReferencesCount	1
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000619686800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0114-5916 1179-1942
IngestDate	Tue Nov 04 01:48:53 EST 2025 Fri Jul 11 09:00:55 EDT 2025 Fri Nov 07 23:35:11 EST 2025 Thu Jan 02 22:39:42 EST 2025 Sat Nov 29 01:45:48 EST 2025 Tue Nov 18 21:33:41 EST 2025 Fri Feb 21 02:48:33 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	5
Language	English
License	Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c474t-843764a74485ced1df9fa69f5553dc3d0a2daf222924302d2f44c8093e95827e3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
OpenAccessLink	https://link.springer.com/10.1007/s40264-021-01044-4
PMID	33606202
PQID	2517259394
PQPubID	32187
PageCount	11
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_8053159 proquest_miscellaneous_2491947122 proquest_journals_2517259394 pubmed_primary_33606202 crossref_citationtrail_10_1007_s40264_021_01044_4 crossref_primary_10_1007_s40264_021_01044_4 springer_journals_10_1007_s40264_021_01044_4
PublicationCentury	2000
PublicationDate	2021-05-01
PublicationDateYYYYMMDD	2021-05-01
PublicationDate_xml	– month: 05 year: 2021 text: 2021-05-01 day: 01
PublicationDecade	2020
PublicationPlace	Cham
PublicationPlace_xml	– name: Cham – name: New Zealand – name: Auckland
PublicationSubtitle	The Official Journal of the International Society of Pharmacovigilance [ISoP]
PublicationTitle	Drug safety
PublicationTitleAbbrev	Drug Saf
PublicationTitleAlternate	Drug Saf
PublicationYear	2021
Publisher	Springer International Publishing Springer Nature B.V
Publisher_xml	– name: Springer International Publishing – name: Springer Nature B.V
References	SchubertIIhlePKosterIInternal confirmation of diagnoses in routine statutory health insurance data: concept with examples and case definitionsGesundheitswesen2010723163221:STN:280:DC%2BC3crhs1ShtQ%3D%3D10.1055/s-0030-1249688 LudvigssonJFAnderssonEEkbomAFeychtingMKimJLReuterwallCExternal review and validation of the Swedish national inpatient registerBMC Public Health.20111145010.1186/1471-2458-11-450 CaiBXuWBortnichakEWatsonDJAn algorithm to identify medical practices common to both the general practice research database and the health improvement network databasePharmacoepidemiol Drug Saf.20122177077410.1002/pds.3277 EMA. Resolor (prucalopride). European Medicines Agency. 2016. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001012/human_med_001030.jsp&mid=WC0b01ac058001d124. Accessed 12 Nov 2020. ChungCPMurrayKTSteinCMHallKRayWAA computer case definition for sudden cardiac deathPharmacoepidemiol Drug Saf.20101956357210.1002/pds.1888 PetersFKreutzburgTKuchenbeckerJMarschallURemmelMDankhoffMQuality of care in surgical/interventional vascular medicine: what can routinely collected data from the insurance companies achieve?Gefässchirurgie.202010.1007/s00772-020-679-4 RuigómezAMartín-MerinoERodríguezLAValidation of ischemic cerebrovascular diagnoses in The Health Improvement Network (THIN)Pharmacoepidemiol Drug Saf.20101957958510.1002/pds.1919 AranaAMargulisAVVaras-LorenzoCBuiCLGilsenanAMcQuayLJValidation of cardiovascular outcomes and risk factors in the clinical practice research datalink in the United KingdomPharmacoepidemiol Drug Saf.202010.1002/pds.5150330911947821285 FortunyFGilsenanACainzos-AchiricaMCanteroAFFlynnRWVGarcia-RodriguezLStudy design and cohort comparability in a study of major cardiovascular events in new users of prucalopride versus polyethylene glycol 3350Drug Saf.201942116711771:CAS:528:DC%2BC1MXhtFWmtbfE10.1007/s40264-019-00836-z AndersohnFSchadeRSuissaSGarbeECyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control studyStroke200637172517301:CAS:528:DC%2BD28XmtVShurY%3D10.1161/01.STR.0000226642.55207.94 AranaAVarasCGonzalez-PerezAGutierrezLBjerrumLGarcia-RodriguezLAHormone therapy and cerebrovascular events: a population-based nested case-control studyMenopause.20061373073610.1097/01.gme.0000233494.28335.71 RoumieCLMitchelEGideonPSVaras-LorenzoCCastellsagueJGriffinMRValidation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health dataPharmacoepidemiol Drug Saf.200817202610.1002/pds.1518 GilsenanAFortunyFCainzos-AchiricaMCanteroAFFlynnRWVGarcia-RodriguezLCardiovascular safety of prucalopride in patients with chronic constipation: a multinational population-based cohort studyDrug Saf.201942117911901:CAS:528:DC%2BC1MXhtFWmur7N10.1007/s40264-019-00835-0 ENCePP. Cohort study of the relative incidence of major cardiovascular events among patients initiating prucalopride versus a matched comparator cohort (EUPAS9200). European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. 2018. http://www.encepp.eu/encepp/viewResource.htm?id=22643. Accessed 12 Nov 2020. HammarNAlfredssonLRosenMSpetzCLKahanTYsbergASA national record linkage to study acute myocardial infarction incidence and case fatality in SwedenInt J Epidemiol.200130Suppl 1S30S3410.1093/ije/30.suppl_1.S30 ThygesenKAlpertJSJaffeASSimoonsMLChaitmanBRWhiteHDThird universal definition of myocardial infarctionCirculation20121262020203510.1161/CIR.0b013e31826e1058 Hicks KA, Hung HMJ, Mahaffey KW, Mehran R, Nissen SE, Stockbridge NL, et al. Standardized definitions for cardiovascular and stroke endpoint events in clinical trials. In: Clinical Data Interchange Standards Consortium (standardized data collection for cardiovascular trials initiative). 2014. Accessed 12 Nov 2020. RayWAVaras-LorenzoCChungCPCastellsagueJMurrayKTSteinCMCardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart diseaseCirc Cardiovasc Qual Outcomes.2009215516310.1161/CIRCOUTCOMES.108.805689 Varas-LorenzoCCastellsagueJStangMRTomasLAguadoJPerez-GutthannSPositive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated databasePharmacoepidemiol Drug Saf.20081784285210.1002/pds.1619 BushMSturmerTStearnsSCSimpsonRJJrBrookhartMARosamondWPosition matters: validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities studyPharmacoepidemiol Drug Saf.2018271085109110.1002/pds.4396 SaccoRLKasnerSEBroderickJPCaplanLRConnorsJJCulebrasAAn updated definition of stroke for the 21st century: a statement for healthcare professionals from the american heart association/american stroke associationStroke2013442064208910.1161/STR.0b013e318296aeca C Varas-Lorenzo (1044_CR5) 2008; 17 I Schubert (1044_CR11) 2010; 72 K Thygesen (1044_CR13) 2012; 126 1044_CR1 A Arana (1044_CR17) 2006; 13 B Cai (1044_CR21) 2012; 21 1044_CR4 CL Roumie (1044_CR19) 2008; 17 F Fortuny (1044_CR3) 2019; 42 N Hammar (1044_CR10) 2001; 30 RL Sacco (1044_CR15) 2013; 44 A Arana (1044_CR6) 2020 F Peters (1044_CR12) 2020 A Gilsenan (1044_CR2) 2019; 42 M Bush (1044_CR7) 2018; 27 WA Ray (1044_CR18) 2009; 2 F Andersohn (1044_CR16) 2006; 37 CP Chung (1044_CR8) 2010; 19 JF Ludvigsson (1044_CR9) 2011; 11 1044_CR14 A Ruigómez (1044_CR20) 2010; 19
References_xml	– reference: RayWAVaras-LorenzoCChungCPCastellsagueJMurrayKTSteinCMCardiovascular risks of nonsteroidal antiinflammatory drugs in patients after hospitalization for serious coronary heart diseaseCirc Cardiovasc Qual Outcomes.2009215516310.1161/CIRCOUTCOMES.108.805689 – reference: PetersFKreutzburgTKuchenbeckerJMarschallURemmelMDankhoffMQuality of care in surgical/interventional vascular medicine: what can routinely collected data from the insurance companies achieve?Gefässchirurgie.202010.1007/s00772-020-679-4 – reference: CaiBXuWBortnichakEWatsonDJAn algorithm to identify medical practices common to both the general practice research database and the health improvement network databasePharmacoepidemiol Drug Saf.20122177077410.1002/pds.3277 – reference: Varas-LorenzoCCastellsagueJStangMRTomasLAguadoJPerez-GutthannSPositive predictive value of ICD-9 codes 410 and 411 in the identification of cases of acute coronary syndromes in the Saskatchewan Hospital automated databasePharmacoepidemiol Drug Saf.20081784285210.1002/pds.1619 – reference: LudvigssonJFAnderssonEEkbomAFeychtingMKimJLReuterwallCExternal review and validation of the Swedish national inpatient registerBMC Public Health.20111145010.1186/1471-2458-11-450 – reference: RuigómezAMartín-MerinoERodríguezLAValidation of ischemic cerebrovascular diagnoses in The Health Improvement Network (THIN)Pharmacoepidemiol Drug Saf.20101957958510.1002/pds.1919 – reference: ThygesenKAlpertJSJaffeASSimoonsMLChaitmanBRWhiteHDThird universal definition of myocardial infarctionCirculation20121262020203510.1161/CIR.0b013e31826e1058 – reference: SaccoRLKasnerSEBroderickJPCaplanLRConnorsJJCulebrasAAn updated definition of stroke for the 21st century: a statement for healthcare professionals from the american heart association/american stroke associationStroke2013442064208910.1161/STR.0b013e318296aeca – reference: ENCePP. Cohort study of the relative incidence of major cardiovascular events among patients initiating prucalopride versus a matched comparator cohort (EUPAS9200). European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. 2018. http://www.encepp.eu/encepp/viewResource.htm?id=22643. Accessed 12 Nov 2020. – reference: AranaAVarasCGonzalez-PerezAGutierrezLBjerrumLGarcia-RodriguezLAHormone therapy and cerebrovascular events: a population-based nested case-control studyMenopause.20061373073610.1097/01.gme.0000233494.28335.71 – reference: FortunyFGilsenanACainzos-AchiricaMCanteroAFFlynnRWVGarcia-RodriguezLStudy design and cohort comparability in a study of major cardiovascular events in new users of prucalopride versus polyethylene glycol 3350Drug Saf.201942116711771:CAS:528:DC%2BC1MXhtFWmtbfE10.1007/s40264-019-00836-z – reference: Hicks KA, Hung HMJ, Mahaffey KW, Mehran R, Nissen SE, Stockbridge NL, et al. Standardized definitions for cardiovascular and stroke endpoint events in clinical trials. In: Clinical Data Interchange Standards Consortium (standardized data collection for cardiovascular trials initiative). 2014. Accessed 12 Nov 2020. – reference: GilsenanAFortunyFCainzos-AchiricaMCanteroAFFlynnRWVGarcia-RodriguezLCardiovascular safety of prucalopride in patients with chronic constipation: a multinational population-based cohort studyDrug Saf.201942117911901:CAS:528:DC%2BC1MXhtFWmur7N10.1007/s40264-019-00835-0 – reference: AranaAMargulisAVVaras-LorenzoCBuiCLGilsenanAMcQuayLJValidation of cardiovascular outcomes and risk factors in the clinical practice research datalink in the United KingdomPharmacoepidemiol Drug Saf.202010.1002/pds.5150330911947821285 – reference: SchubertIIhlePKosterIInternal confirmation of diagnoses in routine statutory health insurance data: concept with examples and case definitionsGesundheitswesen2010723163221:STN:280:DC%2BC3crhs1ShtQ%3D%3D10.1055/s-0030-1249688 – reference: BushMSturmerTStearnsSCSimpsonRJJrBrookhartMARosamondWPosition matters: validation of medicare hospital claims for myocardial infarction against medical record review in the atherosclerosis risk in communities studyPharmacoepidemiol Drug Saf.2018271085109110.1002/pds.4396 – reference: RoumieCLMitchelEGideonPSVaras-LorenzoCCastellsagueJGriffinMRValidation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health dataPharmacoepidemiol Drug Saf.200817202610.1002/pds.1518 – reference: EMA. Resolor (prucalopride). European Medicines Agency. 2016. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001012/human_med_001030.jsp&mid=WC0b01ac058001d124. Accessed 12 Nov 2020. – reference: AndersohnFSchadeRSuissaSGarbeECyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control studyStroke200637172517301:CAS:528:DC%2BD28XmtVShurY%3D10.1161/01.STR.0000226642.55207.94 – reference: ChungCPMurrayKTSteinCMHallKRayWAA computer case definition for sudden cardiac deathPharmacoepidemiol Drug Saf.20101956357210.1002/pds.1888 – reference: HammarNAlfredssonLRosenMSpetzCLKahanTYsbergASA national record linkage to study acute myocardial infarction incidence and case fatality in SwedenInt J Epidemiol.200130Suppl 1S30S3410.1093/ije/30.suppl_1.S30 – volume: 44 start-page: 2064 year: 2013 ident: 1044_CR15 publication-title: Stroke doi: 10.1161/STR.0b013e318296aeca – ident: 1044_CR14 – year: 2020 ident: 1044_CR6 publication-title: Pharmacoepidemiol Drug Saf. doi: 10.1002/pds.5150 – volume: 19 start-page: 563 year: 2010 ident: 1044_CR8 publication-title: Pharmacoepidemiol Drug Saf. doi: 10.1002/pds.1888 – volume: 19 start-page: 579 year: 2010 ident: 1044_CR20 publication-title: Pharmacoepidemiol Drug Saf. doi: 10.1002/pds.1919 – volume: 21 start-page: 770 year: 2012 ident: 1044_CR21 publication-title: Pharmacoepidemiol Drug Saf. doi: 10.1002/pds.3277 – volume: 17 start-page: 842 year: 2008 ident: 1044_CR5 publication-title: Pharmacoepidemiol Drug Saf. doi: 10.1002/pds.1619 – volume: 2 start-page: 155 year: 2009 ident: 1044_CR18 publication-title: Circ Cardiovasc Qual Outcomes. doi: 10.1161/CIRCOUTCOMES.108.805689 – volume: 42 start-page: 1179 year: 2019 ident: 1044_CR2 publication-title: Drug Saf. doi: 10.1007/s40264-019-00835-0 – volume: 30 start-page: S30 issue: Suppl 1 year: 2001 ident: 1044_CR10 publication-title: Int J Epidemiol. doi: 10.1093/ije/30.suppl_1.S30 – volume: 126 start-page: 2020 year: 2012 ident: 1044_CR13 publication-title: Circulation doi: 10.1161/CIR.0b013e31826e1058 – volume: 11 start-page: 450 year: 2011 ident: 1044_CR9 publication-title: BMC Public Health. doi: 10.1186/1471-2458-11-450 – volume: 72 start-page: 316 year: 2010 ident: 1044_CR11 publication-title: Gesundheitswesen doi: 10.1055/s-0030-1249688 – year: 2020 ident: 1044_CR12 publication-title: Gefässchirurgie. doi: 10.1007/s00772-020-679-4 – volume: 13 start-page: 730 year: 2006 ident: 1044_CR17 publication-title: Menopause. doi: 10.1097/01.gme.0000233494.28335.71 – volume: 17 start-page: 20 year: 2008 ident: 1044_CR19 publication-title: Pharmacoepidemiol Drug Saf. doi: 10.1002/pds.1518 – volume: 37 start-page: 1725 year: 2006 ident: 1044_CR16 publication-title: Stroke doi: 10.1161/01.STR.0000226642.55207.94 – ident: 1044_CR4 – ident: 1044_CR1 – volume: 27 start-page: 1085 year: 2018 ident: 1044_CR7 publication-title: Pharmacoepidemiol Drug Saf. doi: 10.1002/pds.4396 – volume: 42 start-page: 1167 year: 2019 ident: 1044_CR3 publication-title: Drug Saf. doi: 10.1007/s40264-019-00836-z
SSID	ssj0008268
Score	2.331071
Snippet	Introduction A multinational post-authorization safety study assessed cardiovascular safety in initiators of prucalopride for chronic constipation compared... A multinational post-authorization safety study assessed cardiovascular safety in initiators of prucalopride for chronic constipation compared with a matched... Introduction A multinational post-authorization safety study assessed cardiovascular safety in initiators of prucalopride for chronic constipation compared...
SourceID	pubmedcentral proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	541
SubjectTerms	Adjudication Algorithms Automation Benzofurans - adverse effects Cerebral infarction Clinical medicine Constipation Data sources Databases, Factual Drug Safety and Pharmacovigilance Electronic Health Records Gold Heart attacks Hospitalization Hospitals Humans Information services Information Storage and Retrieval Initiators Medical records Medicine Medicine & Public Health Myocardial infarction Myocardial Infarction - chemically induced Myocardial Infarction - epidemiology Original Original Research Article Patients Pharmacology/Toxicology Polyethylene glycol Practice research Questionnaires Safety Stroke United Kingdom - epidemiology
SummonAdditionalLinks	– databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgIISE-CgDCgMdEtoLtZTaThM_orGJBzZVdFR7ixx_aEUjQUmK1P-JP5Kz81GVARI836VJ6vP5d7m73xHyZppKLfMc97dLEiqYSKjS0lHBrc55mhsbiOeXH5Ozs_TiQs67prC6r3bvU5LBUw_NbhjpzAT1JQU-hhBU3CS38LhL_cCGT4vl4H8RMAf_i0ifxoh-ulaZ3__G7nF0DWNeL5X8JV8ajqGTB__3Ag_J_Q52wrvWTh6RG7YYkTunXWJ9RA7nLYX1ZgLn246segKHMN-SW29G5F77nQ_a9qXH5Efb6eu6T3-gCgNLxPbtqCYoHZyqL2UFRzt1r3DsyyxrWBWAABRa4At-voopv8J71ShYhKxCDejArtYGpairIPQLU1_W6o9f8KOGqVo3l2XV9ZPCQjnbbMDXR2787eeV59ot8a8ydp98Pjk-P_pAuwkQVItENDQV6P-ESjCGjLU1U-OkUzPp4jjmRnMTKWaU8yPJmeARM8wJodNIcivjlCWWPyF7RVnYZwQcQhGXzzCgmEkh8yh3mk9djuErt1Fi4zGZ9oaQ6Y4e3U_puMoGYuewfhmuXxbWLxNj8na45ltLDvJX7YPevrLOUdSZZ4zDCJRLFL8exLjFfd5GFbZco46QU4kggrExedqa43A7zjECZRFKkh1DHRQ8ffiupFhdBhrx1PvfWI7JpDfX7WP9-S2e_5v6C3KXBYv3JaIHZK-p1vYlua2_N6u6ehU27k-dMT7g priority: 102 providerName: Springer Nature
Title	Identification and Validation of Major Cardiovascular Events in the United Kingdom Data Sources Included in a Multi-database Post-authorization Safety Study of Prucalopride
URI	https://link.springer.com/article/10.1007/s40264-021-01044-4 https://www.ncbi.nlm.nih.gov/pubmed/33606202 https://www.proquest.com/docview/2517259394 https://www.proquest.com/docview/2491947122 https://pubmed.ncbi.nlm.nih.gov/PMC8053159
Volume	44
WOSCitedRecordID	wos000619686800001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1179-1942 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0008268 issn: 0114-5916 databaseCode: 7X7 dateStart: 20080101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1179-1942 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0008268 issn: 0114-5916 databaseCode: 7RV dateStart: 20080101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: Proquest Central customDbUrl: eissn: 1179-1942 dateEnd: 20241209 omitProxy: false ssIdentifier: ssj0008268 issn: 0114-5916 databaseCode: BENPR dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink customDbUrl: eissn: 1179-1942 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0008268 issn: 0114-5916 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dbtMwFLZg4wJp4mf8FcZ0kNBuaEQSO018hWB04oJVUTuq3kWOf7SiLRlNitQ7XoE34Zl4Eo6dNFWZ2A03liK7ahx9Pv6Ofc53CHkdJFzyPMf1beLYYyGLPSG58RjVMqdJrrQTnp9-jkejZDbjaXvgVrVhlWub6Ay1KqU9I39rpbWQqlPO3l1982zVKHu72pbQuE12A8uNEc_xeNpZYqTOzhIj5_ci5EFt0oxLnUO_acA8G6BgPRLmse2N6RrbvB40-dfNqduQTu7_71QekHstFYX3DXYeklu62CdHaaNlverD2SY1q-rDEaQblevVPtlrDvygyWN6RH41Kb-mPQMEUSiYIslvajZBaeBUfC0XcLwVAAtDG29ZwbwAZKLQMGCwhVZUeQkfRS1g4q4XKkBLdrFU2ItjBbjE4d8_ftoIV7sTg606jM9iWZ_jXJvkUpgIo-sV2GDJlX2FdGGFd0v8oko_Jl9OhmfHn7y2HIQnWcxqL2FoDJmI0aGMpFaBMtyIATdRFFElqfJFqISx9clDRv1QhYYxmficah4lYazpE7JTlIV-RsAgLzH5AL2LAWc893MjaWBy9GWp9mMd9UiwxkImW610W7LjIutUnh1-MsRP5vCTsR550_3mqlEKuXH0wRobWWs1qmwDjB551XXjereXOKLQ5RLHMB5wZBRh2CNPG0R2f0cpuqOhjz3xFla7AVZLfLunmJ87TfHEGuOI90h_jerNa_17Fs9vnsULcjd0K8zGhx6QnXqx1C_JHfm9nleLQ7dWbTuLXZsckt0Pw1E6xqdReorteDL9A7zJTyE
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxELZKQQIJ8SivQIFBgl7IisTrza4PCKE-1KppFKmlym3xrm01qOyWbALKjb_AH0H8Jn4JM95HFCp664Hjyt6HvTPj-eyZbxh72Y1kKpME9duGoSe4CD2VSusJ36SJHyXaOOL54344GESjkRyusJ91LgyFVdY20Rlqnae0R_6GqLXQVfeleHf2xaOqUXS6WpfQKMVi38y_IWQr3u5t4f99xfnO9tHmrldVFfBSEYqpFwnUKaFCxCVBanRXW2lVT9ogCHyd-rqjuFaWylxz4Xe45laINELgb2QQ8dD4-Nwr7Cra8ZDAXjhqAB6upi71jjCGF6DfVSXpuFQ9xGk94VFABCEg4YnlhfCcd3s-SPOvk1q3AO7c_t-m7g67Vbna8L7UjbtsxWRrbGNYcnXP23C0SD0r2rABwwWL93yN3Sw3NKHM07rHfpUpzbba4wSVaThGEFPWpILcwoH6lE9gcynAF7YpnrSAcQboaUPp4QMVktH5Z9hSUwWH7vikALTUpzONrdhXgUuM_v39B0XwkqcBVFUZr9VseoJzWybPwqGyZjoHCgad0ycMJ0QsnOMf1OY--3Aps_uArWZ5Zh4xsOh32aSH6KknhUw6iU39rk0Qq_umE5qgxbq17MVpxQVPJUlO44bF2slrjPIaO3mNRYu9bu45K5lQLuy9XstiXFnFIl4IYou9aJrRntEhlcpMPsM-QnYlekyct9jDUgOa1_k-wm3ewZZwSTeaDsSVvtySjU8cZ3pEi00gW6xda9His_49iscXj-I5u757dNCP-3uD_SfsBnfaTbGw62x1OpmZp-xa-nU6LibPnJ0A9vGytesP-Umkhw
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VFCEkxKO8AgUGCXohVp3ddew9IARNKqqWyKKl6s2svbtqULFL7IBy4y_wTzjzc_glzPoVhYreeuBo7Sa21_P4ZnfmG0Ke9QORiDhG_Ta-73DKfUcmwjic6SRmQax0STx_uOePx8HRkQhXyK-mFsamVTY2sTTUKkvsHvmmpdZCqM4E3zR1WkQ43H51-sWxHaTsSWvTTqMSkV09_4bhW_5yZ4jf-jml26ODrbdO3WHASbjPCyfgqF9c-hijeIlWfWWEkQNhPM9jKmHKlVRJY1teU85cqqjhPAlcwbTwAuprhv97iaz6CDJ4h6y-GY3D960fQOBe-gGMOBwPUVhdslMW7mHUNuCOTY-w8RB3-LJbPIN1z6Zs_nVuW7rD7Rv_80LeJNdrEA6vK625RVZ0ukY2worFe96Dg0VRWt6DDQgX_N7zNXKt2uqEqoLrNvlZFTubevcTZKrgEMObqlsVZAbeyU_ZFLaWUn9hZDNNc5ikgBgcKuwPtsWMyj7DUBYS9suDlRzQhp_MFI7iXAllyfTv7z9sbq_FIGD7LeO1nBXHuLZVWS3sS6OLOdg00bl9hHBqKYcz_JpK3yEfLmR175JOmqX6PgGDiMzEA4yrBoKL2I1NwvomxiieadfXXpf0GzmMkpol3jYrOYlafutSdiOU3aiU3Yh3yYv2N6cVR8q5s9cbuYxqe5lHC6HskqftMFo6e3wlU53NcA4XfYFYitIuuVdpQ3s7xjAQpy6O-Et60k6wLOrLI-nkuGRTD6wb8kSX9BqNWjzWv9_iwflv8YRcQaWK9nbGuw_JVVoquk2SXSedYjrTj8jl5GsxyaePa6MB5ONFq9cfZh6upw
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+and+Validation+of+Major+Cardiovascular+Events+in+the+United+Kingdom+Data+Sources+Included+in+a+Multi-database+Post-authorization+Safety+Study+of+Prucalopride&rft.jtitle=Drug+safety&rft.au=Ruig%C3%B3mez%2C+Ana&rft.au=Plana%2C+Estel&rft.au=Gilsenan%2C+Alicia&rft.au=Fortuny%2C+Joan&rft.date=2021-05-01&rft.pub=Springer+International+Publishing&rft.issn=0114-5916&rft.eissn=1179-1942&rft.volume=44&rft.issue=5&rft.spage=541&rft.epage=551&rft_id=info:doi/10.1007%2Fs40264-021-01044-4&rft_id=info%3Apmid%2F33606202&rft.externalDocID=PMC8053159
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0114-5916&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0114-5916&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0114-5916&client=summon